LIVE VIEW · ENGNenGene Therapeutics Inc.HealthcareENGN research Sign up to open the full interactive terminal, save boards, and get alerts
ENGN · Live chart
Loading live chart
ENGN · Smart-money composite
Not enough smart-money filings yet for a composite score.
ENGN · Recent signals
Point72 Asset Management, L.P. cut 69% of ENGN (2026Q1)HIGHSHORTJul 24
RENAISSANCE TECHNOLOGIES LLC added +651% to ENGN (2026Q1)HIGHLONGJul 24
Q1-2026: Beat consensus by 22.9% - EPS $-0.44 vs $-0.571 estimateMEDIUMLONGJun 20
Q2-2026: Beat consensus by 10.3% - EPS $-0.43 vs $-0.4795 estimateMEDIUMLONGJun 18
Q4-2025: Missed consensus by 25.9% - EPS $-0.73 vs $-0.5796 estimateMEDIUMSHORTMay 29
Beat consensus by 22.9% - EPS $-0.44 vs $-0.571 estimateMEDIUMLONGMay 29
Q3-2025: Missed consensus by 11.5% - EPS $-0.57 vs $-0.5111 estimateMEDIUMSHORTMay 29
ENGN · Institutional holders
No 13F holdings on file for ENGN.
Live alerts on ENGN
Live alerts on ENGNGet pinged the moment insiders, congress, or 13F funds move on ENGN.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for ENGN.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock